ANDA 91567, held by Sun Pharmaceutical Industries. Fexofenadine Hydrochloride.
As of Nov 22, 2026, ANDA 91567 (Children's Fexofenadine Hydrochloride Hives, Children's Fexofenadine Hydrochloride Allergy, Fexofenadine Hydrochloride Hives), held by Sun Pharmaceutical Industries, was first approved by FDA on Feb 6, 2012, with 1 approved supplement and 0 published complete response letters.
Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 6, 2012 | Original application | Approved | None posted |
| Children's Fexofenadine Hydrochloride Hives30MG · tablet;oral | Fexofenadine Hydrochloride | Discontinued |
| Children's Fexofenadine Hydrochloride Allergy30MG · tablet;oral | Fexofenadine Hydrochloride | Discontinued |
| Fexofenadine Hydrochloride Hives60MG · tablet;oral | Fexofenadine Hydrochloride | Discontinued |
| Fexofenadine Hydrochloride Allergy60MG · tablet;oral | Fexofenadine Hydrochloride | Discontinued |
| Fexofenadine Hydrochloride Hives180MG · tablet;oral | Fexofenadine Hydrochloride | OTC |
| Fexofenadine Hydrochloride Allergy180MG · tablet;oral | Fexofenadine Hydrochloride | OTC |
| Feb 25, 2015 | Supplement 1Manufacturing | Approved | None posted |
| Feb 6, 2012 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters